Q2i's Outcome-Measures Software Helping Improve Quality of Treatment for Substance Use Disorder
BOSTON, Nov. 15, 2018 /PRNewswire/ -- Q2i, a provider of technology that improves patient care by enabling better information exchange between patients and their healthcare teams, today announced that their products now include survey and outcome-measure features that allow providers to better understand patient progress and make continuous improvements in how they treat patients recovering from Substance Use Disorder.
The new outcome-measures functionality enables healthcare teams to obtain and understand treatment, post-treatment, and continuing care outcome data. In addition, it supports collecting and reporting performance data using approved measurement tools such as the National Outcome Measures (NOMs) surveys for population-focused programs, as required of SAMHSA grantees.
Q2i's products, Opioid Addiction Recovery System (OARS) and Continuing Alumni Support Application (CASA), consist of a patient mobile app and a care team portal. OARS is used by providers of MAT programs who want to increase support, improve treatment plan adherence and reduce program dropout. CASA is used by treatment facilities to maintain connection when patients have left the facility and deliver extended/ continuing care.
Both OARS and CASA include the outcome-measures and survey functionality. Now, healthcare teams can easily design their own surveys or use the built-in standard surveys and publish them securely to OARS and CASA. Survey responses enable and inform a better understanding of outcomes, facilitate continuous improvements, and a results-oriented approach to treatment and support.
"Collecting data from patients in recovery and alumni of treatment facilities can prove difficult and costly for many reasons," said Steven Jenkins, CEO of Q2i. "We believe that embedding a survey in our apps, which the patient is already using and benefitting from, will lead to higher response rates – with higher-quality data – than surveys delivered by more traditional methods such as email or telephone."
RTI International, a non-profit research organization that provides effective, evidence-based solutions for today's complex healthcare challenges, has studied how capturing SUD patient feedback data can be a vital component of improving patients' treatment plans.
"Measurement-based care is an evidence-based practice that can improve outcomes for patients treated for addictions," said Tami L. Mark, PhD, MBA, Senior Director, Behavioral Health Financing and Quality Measurement at RTI International. "Technologies that make it easier to capture outcomes during and after treatment will be critical for adoption of this effective treatment approach."
Q2i collaborates with multidisciplinary healthcare teams, providers and payers to understand and then realize unmet technology needs. We facilitate improvements in patient care by supporting patients with their treatment plans through better connection and information exchange with their healthcare teams.
About RTI International
RTI International is an independent, nonprofit research institute dedicated to improving the human condition. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across the social and laboratory sciences, engineering, and international development.
SOURCE Q2i
Share this article